Read the quarter in context.
A source-linked quarter view: reported numbers, management language, guidance, and the risks that should carry forward.
ConCallIQ research layer
Signal, with the source still visible.
Use the controls below to narrow the view, then follow the evidence into the next layer of context.
Revenue
₹73 Cr
verification pending
Revenue YoY
—
reported change
EBITDA
₹16.7 Cr
latest reported figure
Source
bse pending
record provenance
Actual signal trajectory
Where this quarter sits.
Quarter read
What the record says.
Jagsonpal reported a flattish Q3 FY26 with revenue of ₹73 crore and PAT of ₹12.5 crore (+10% YoY), but growth was below expectations due to internal recalibration and a slower-growing RPM (3-3.5% vs IPM 8%). EBITDA margin held at 22.7% while cash generation remained strong at ₹15 crore in the quarter. Management attributed the softness to GST-related inventory correction in Q2 and deliberate field force realignment under new leadership, which is now largely complete. Guidance points to double-digit revenue growth from Q4, targeting 50% above industry growth. Key risks include sustained RPM sluggishness and elevated asset valuations hindering M&A deployment of the ₹176 crore cash pile.
Colored figures show movement against the previous available record.
Guidance to track
- Management expects revenue growth to accelerate to double digits (upward of 10%) from Q4 FY26, driven by completion of field force realignment and improved execution.
- The company aims to grow at 50% more than the industry growth rate (industry expected at 7.5-8.5%) in the near term.
- Product launches in high-growth therapeutic areas with better yield per patient are expected by the end of H1 FY27 to boost volume and value growth.
Risks flagged
- The company's relevant market (RPM) grew at 3-3.5% vs IPM 8%, and if this cyclicity persists, it could cap growth despite internal improvements.
- Management noted that assets are highly priced, making disciplined M&A difficult, which could delay productive use of the ₹176 crore cash pile.
- Management acknowledged that MR productivity is below peer levels, and improvement is critical to achieving double-digit growth targets.
Key quotes
- We are confident of a growth acceleration to double digit from Q4 itself.
- Our idea suggests at least what I'm aiming in the short term is 50% more than the industry growth.
- If we are unable to use our cash efficiently, we would rather return it to the shareholders in the right format.
Research modules